Related Experiment Video
Updated: Jun 5, 2026

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions.
Qi Li1, Michael Michaud, Sandra Canosa
1Department of Pathology, School of Medicine, Yale University, 310 Cedar Street, P.O. Box 208023, New Haven, CT 06520-8023, USA.
Targeting GSK-3β may improve brain development and recovery from injury in premature infants. Inhibiting GSK-3β in mouse models normalized neural stem cell and vascular behaviors, suggesting therapeutic potential.
Area of Science:
- Neuroscience
- Developmental Biology
- Molecular Biology
Background:
- Neural stem cells (NSC) and microvascular endothelial cells (BEC) dynamically interact in brain neurogenic areas.
- Glycogen synthase kinase-3 beta (GSK-3β) acts as a signaling node, influencing NSC and BEC behaviors.
- Mouse models (C57BL/6 and CD-1) exhibit differential responses to hypoxic insult, mimicking premature infant vulnerability.
Purpose of the Study:
- To investigate the role of GSK-3β as a signaling node in modulating NSC and BEC behaviors.
- To compare the molecular and cellular responses to hypoxic insult between C57BL/6 and CD-1 mice.
- To explore the therapeutic potential of targeting GSK-3β for improving outcomes after hypoxic injury.
Main Methods:
- Comparative analysis of GSK-3β activation, downstream signaling molecules (HIF-1α, HIF-2α, β-catenin), and cell behavior markers in C57BL/6 and CD-1 mice.
- In vitro studies using cultured NSC and BEC from both mouse strains.
- Pharmacological inhibition of GSK-3β using SB412682 in C57BL/6 models.
Main Results:
- CD-1 mice showed less GSK-3β/β-catenin phosphorylation and higher expression of HIF-1α/2α, BDNF, SDF-1, VEGF, β-III-tubulin, and cleaved notch-1 compared to C57BL/6.
- CD-1 NSC exhibited enhanced proliferation and migration with reduced apoptosis and differentiation; CD-1 BEC showed increased angiogenesis.
- GSK-3β inhibition in C57BL/6 models normalized NSC and BEC behaviors to CD-1 levels.
Conclusions:
- GSK-3β is a critical signaling node regulating NSC and BEC behaviors relevant to brain development and injury response.
- Differential GSK-3β activity underlies varied responses to hypoxia in mouse models, relevant to premature infants.
- Targeting GSK-3β presents a promising therapeutic strategy for neuroprotection and recovery from hypoxic insults.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Regulation of Angiogenesis and Blood Supply

